Market Exclusive

MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard: Transfer of Listing

On March1, 2017, Nasdaq issued a determination that the Company
has evidenced compliance with the minimum stockholders equity
requirement for continued listing on the Nasdaq Capital Market.
Item 7.01 Regulation FD Disclosure
On March 2, 2017, Medovex Corp. (the Company) issued a press
release upon receiving Nasdaqs determinations that the Company
has evidenced compliance with NASDAQs stockholders equity
requirement for continued listing. . A copy of the press release
is attached hereto as Exhibit 99.1 and incorporated herein by
reference.
The information contained in this Current Report on Form 8-K
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or incorporated by reference in any filing under the Securities
Act of 1933, as amended (the Securities Act) or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing. The furnishing of the information in this Current
Report on Form 8-K is not intended to, and does not, constitute a
representation that such furnishing is required by Regulation FD
or that the information contained in this Current Report on Form
8-K constitutes material investor information that is not
otherwise publicly available.
The Securities and Exchange Commission encourages registrants to
disclose forward-looking information so that investors can better
understand the future prospects of a registrant and make informed
investment decisions. This Current Report on Form 8-K and
exhibits may contain these types of statements, which are
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, and which involve
risks, uncertainties and reflect the Registrants judgment as of
the date of this Current Report on Form 8-K. Forward-looking
statements may relate to, among other things, operating results
and are indicated by words or phrases such as expects, should,
will, and similar words or phrases. These statements are subject
to inherent uncertainties and risks that could cause actual
results to differ materially from those anticipated at the date
of this Current Report on Form 8-K. The Company disclaims any
obligation to, and will not, update any forward-looking
statements to reflect events or circumstances after the date
hereof. Investors are cautioned not to rely unduly on
forward-looking statements when evaluating the information
presented within.
Item 9.01 Financial Statements and Exhibits
(d)Exhibits.
Exhibit No.
Description
99.1
Press Release dated March 2, 2017

MEDOVEX CORP. (NASDAQ:MDVX) Recent Trading Information
MEDOVEX CORP. (NASDAQ:MDVX) closed its last trading session down -0.08 at 1.17 with 20,320 shares trading hands.

Exit mobile version